Monoclonal antibodies specific for rat relaxin. VIII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces water consumption in rats.
Recent studies demonstrated that exogenous relaxin promoted drinking in nonpregnant rats. The purpose of this investigation was to determine the influence of endogenous relaxin on water consumption in pregnant rats. To that end, a monoclonal antibody specific for rat relaxin, designated MCA1, was used to passively neutralize endogenous relaxin throughout the second half of pregnancy in intact rats. Five milligrams of highly purified MCA1 were administrated iv to rats daily from days 12-22 of pregnancy. Controls received either a monoclonal antibody for fluorescein (monoclonal antibody control) or PBS (vehicle control). The amount of water consumed and both the total duration of water consumption and the total number of episodes when water was consumed were determined daily during both dark and light periods for all treatment groups. From days 13-22 of pregnancy, all three of these parameters of water consumption increased during the 10-h dark period (P < 0.01), but not during the 14-h light period. The mean daily water consumption in MCA1-treated rats was significantly less than that in controls (P < 0.05). Relaxin's effects on water consumption were limited to the 14-h light period (P < 0.01). No difference was found in daily water consumption between the MCA1-treated and control groups during the 10-h dark period. There was a tendency during the light period for both the total duration of water consumption (P = 0.06) and the total number of episodes when water was consumed (P = 0.13) to be less in MCA1-treated rats than in controls. Food consumption and body weight increased as pregnancy progressed, but no differences were found among the three treatment groups. We conclude that endogenous relaxin has effects on water consumption. It promotes water consumption during the daily light period in the second half of pregnancy in rats. Thus, relaxin may be a dipsogenic agent.
Zhao
S
S
Department of Physiology, University of Illinois-Urbana-Champaign 61801, USA.
Malmgren
C H
CH
Shanks
R D
RD
Sherwood
O D
OD
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000918:Antibody Specificity; D002584:Cervix Uteri / Q000033:anatomy & histology / Q000502:physiology; D004327:Drinking Behavior / Q000502:physiology*; D005247:Feeding Behavior / Q000502:physiology; D005260:Female; D007116:Immunization, Passive; D008098:Litter Size; D009929:Organ Size; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000502:physiology*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012065:Relaxin / Q000276:immunology / Q000502:physiology*; D013997:Time Factors
D000911:Antibodies, Monoclonal; D012065:Relaxin